Lobe Sciences LtdOTCQB:LOBEFView on Canadian Exchange
- LAST PRICE0.0144
- TODAY'S CHANGE (%)0.0000 (0.3484%)
- Bid / Lots0.0135/ 100
- Ask / Lots0.0180/ 600
- Open / Previous Close0.0145 / 0.0144
- Day Range
- 52 Week Range
- Volume3,040
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LOBEF |
|---|---|---|
| 10:03 ET | 2387 | 0.01445 |
| 12:54 ET | 250 | 0.0135 |
| 01:44 ET | 400 | 0.0144 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Lobe Sciences Ltd | 1.2M | 0.0x | --- |
Company Information
Lobe Sciences Ltd. is a Canada-based biopharmaceutical company focused on developing patient-friendly, practical psychedelic medicines. The Company, through collaborations with partners, is engaged in drug research and development using sub-hallucinatory doses of proprietary compounds to treat Orphan diseases. Its new chemical entities, L-130 and L-131, are being developed to address unmet medical needs such as Chronic Cluster Headaches and other Orphan diseases. In addition, the Company is commercializing Altemia, for the treatment of patients diagnosed with Sickle Cell Disease. Its subsidiaries include Eleusian Biosciences Corp., Lobe Sciences Australia Pty Ltd. and Altemia & Company, LLC.
Contact Information
- Headquarters
- Suite 1400-1199 West Hastings StreetVANCOUVER, BC, Canada V6E 3T2
- Phone
- 604-834-9499
- Fax
- 604-628-1249
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2M |
|---|---|
Revenue (TTM) | $976.7K |
Shares Outstanding | 79.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.49 |
EPS | $-0.04 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -304.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
